{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:42:48Z","timestamp":1766086968395},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T00:00:00Z","timestamp":1407283200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1745-6215-15-311","type":"journal-article","created":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T03:01:05Z","timestamp":1407294065000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"15","author":[{"given":"Roman","family":"Kloeckner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Ruckes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Kronfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus Alexander","family":"W\u00f6rns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arndt","family":"Weinmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Robert","family":"Galle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hauke","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Otto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waltraud","family":"Eichhorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Schreckenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Dueber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Bernhard","family":"Pitton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,6]]},"reference":[{"key":"2186_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000077991","volume":"66","author":"MJ Olnes","year":"2004","unstructured":"Olnes MJ, Erlich R: A review and update on cholangiocarcinoma. Oncology. 2004, 66: 167-179.","journal-title":"Oncology"},{"key":"2186_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","volume":"224","author":"A Nakeeb","year":"1996","unstructured":"Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, Hruban RH, Lillemoe KD, Yeo CJ, Cameron JL: Cholangiocarcinoma - a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996, 224: 463-473.","journal-title":"Ann Surg"},{"key":"2186_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1136\/gut.48.6.816","volume":"48","author":"SD Taylor-Robinson","year":"2001","unstructured":"Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A, Khan SA, Elliott P, Thomas HC: Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968\u20131998. Gut. 2001, 48: 816-820.","journal-title":"Gut"},{"key":"2186_CR4","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","volume":"33","author":"T Patel","year":"2001","unstructured":"Patel T: Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001, 33: 1353-1357.","journal-title":"Hepatology"},{"key":"2186_CR5","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","volume":"366","author":"SA Khan","year":"2005","unstructured":"Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD: Cholangiocarcinoma. Lancet. 2005, 366: 1303-1314.","journal-title":"Lancet"},{"key":"2186_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/s-2004-828889","volume":"24","author":"Y Shaib","year":"2004","unstructured":"Shaib Y, El-Serag HB: The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004, 24: 115-125.","journal-title":"Semin Liver Dis"},{"key":"2186_CR7","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1053\/j.gastro.2004.12.048","volume":"128","author":"YH Shaib","year":"2005","unstructured":"Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA: Risk factors of intrahepatic cholangiocarcinoma in the United States: a case\u2013control study. Gastroenterology. 2005, 128: 620-626.","journal-title":"Gastroenterology"},{"key":"2186_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","volume":"36","author":"A Bergquist","year":"2002","unstructured":"Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, Danielsson A, Hultcrantz R, Lindgren S, Prytz H, Sandberg-Gertzen H, Almer S, Granath F, Broome U: Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol. 2002, 36: 321-327.","journal-title":"J Hepatol"},{"key":"2186_CR9","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","volume":"100","author":"JM Farrant","year":"1991","unstructured":"Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, Williams R: Natural-history and prognostic variables in primary sclerosing cholangitis. Gastroenterology. 1991, 100: 1710-1717.","journal-title":"Gastroenterology"},{"key":"2186_CR10","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1002\/1097-0142(19930415)71:8<2461::AID-CNCR2820710806>3.0.CO;2-7","volume":"71","author":"MF Chen","year":"1993","unstructured":"Chen MF, Jan YY, Wang CS, Hwang TL, Jeng LB, Chen SC, Chen TJ: A reappraisal of cholangiocarcinoma in patient with hepatolithiasis. Cancer. 1993, 71: 2461-2465.","journal-title":"Cancer"},{"key":"2186_CR11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/BF00294744","volume":"19","author":"S Kubo","year":"1995","unstructured":"Kubo S, Kinoshita H, Hirohashi K, Hamba H: Hepatolithiasis associated with cholangiocarcinoma. World J Surg. 1995, 19: 637-641.","journal-title":"World J Surg"},{"key":"2186_CR12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/00042737-200209000-00016","volume":"14","author":"N Lesurtel","year":"2002","unstructured":"Lesurtel N, Regimbeau JM, Fargesa O, Colombat M, Sauvanet A, Beighiti J: Intrahepatic cholangiocarcinoma and hepatolithiasis: an unusual association in Western countries. Eur J Gastroenterol Hepatol. 2002, 14: 1025-1027.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2186_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/bjs.1800820333","volume":"82","author":"PM Hewitt","year":"1995","unstructured":"Hewitt PM, Krige JEJ, Bornman PC, Terblanche J: Choledochal cysts in adults. Br J Surg. 1995, 82: 382-385.","journal-title":"Br J Surg"},{"key":"2186_CR14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/00000658-199411000-00007","volume":"220","author":"PA Lipsett","year":"1994","unstructured":"Lipsett PA, Pitt HA, Colombani PM, Boitnott JK, Cameron JL: Choledochal cyst disease - a changing pattern of presentation. Ann Surg. 1994, 220: 644-652.","journal-title":"Ann Surg"},{"key":"2186_CR15","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/hep.510280404","volume":"28","author":"HT Sorensen","year":"1998","unstructured":"Sorensen HT, Friis S, Olsen JH, Thulstrup M, Mellemkjaer L, Linet M, Trichopoulos D, Vilstrup H, Olsen J: Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology. 1998, 28: 921-925.","journal-title":"Hepatology"},{"key":"2186_CR16","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1023\/A:1013747228572","volume":"12","author":"F Donato","year":"2001","unstructured":"Donato F, Gelatti U, Tagger A, Favret M, Ribero ML, Callea F, Martelli C, Savio A, Trevisi P, Nardi G: Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case\u2013control study in Italy. Cancer Causes Control. 2001, 12: 959-964.","journal-title":"Cancer Causes Control"},{"key":"2186_CR17","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/sj.bjc.6605063","volume":"100","author":"CH Lee","year":"2009","unstructured":"Lee CH, Chang CJ, Lin YJ, Yeh CN, Chen MF, Hsieh SY: Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J Cancer. 2009, 100: 1765-1770.","journal-title":"Br J Cancer"},{"key":"2186_CR18","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.1349-7006.2004.tb02492.x","volume":"95","author":"S Yamamoto","year":"2004","unstructured":"Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T, Takemura S, Tanaka H, Yamazaki O, Hirohashi K, Tanaka T: Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci. 2004, 95: 592-595.","journal-title":"Cancer Sci"},{"key":"2186_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","volume":"245","author":"ML DeOliveira","year":"2007","unstructured":"DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MC, Yeo CJ, Schulick RD: Cholangiocarcinoma - thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007, 245: 755-762.","journal-title":"Ann Surg"},{"key":"2186_CR20","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1056\/NEJM199706263362607","volume":"336","author":"S Saini","year":"1997","unstructured":"Saini S: Imaging of the hepatobiliary tract. N Engl J Med. 1997, 336: 1889-1894.","journal-title":"N Engl J Med"},{"key":"2186_CR21","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1148\/radiographics.19.5.g99se081199","volume":"19","author":"CM Bloom","year":"1999","unstructured":"Bloom CM, Langer B, Wilson SR: Role of US in the detection, characterization, and staging of cholangiocarcinoma. Radiographics. 1999, 19: 1199-1218.","journal-title":"Radiographics"},{"key":"2186_CR22","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1634\/theoncologist.11-8-913","volume":"11","author":"JM Slattery","year":"2006","unstructured":"Slattery JM, Sahani DV: What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma?. Oncologist. 2006, 11: 913-922.","journal-title":"Oncologist"},{"key":"2186_CR23","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1148\/radiology.198.3.8628885","volume":"198","author":"R Robledo","year":"1996","unstructured":"Robledo R, Muro A, Prieto ML: Extrahepatic bile duct carcinoma: US characteristics and accuracy in demonstration of tumors. Radiology. 1996, 198: 869-873.","journal-title":"Radiology"},{"key":"2186_CR24","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1097\/00004728-199909000-00004","volume":"23","author":"Y Zhang","year":"1999","unstructured":"Zhang Y, Uchida M, Abe T, Nishimura H, Hayabuchi N, Nakashima Y: Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI. J Comput Assist Tomogr. 1999, 23: 670-677.","journal-title":"J Comput Assist Tomogr"},{"key":"2186_CR25","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.2214\/ajr.170.6.9609160","volume":"170","author":"LH Schwartz","year":"1998","unstructured":"Schwartz LH, Coakley FV, Sun Y, Blumgart LH, Fong YM, Panicek DM: Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangiopancreatography. Am J Roentgenol. 1998, 170: 1491-1495.","journal-title":"Am J Roentgenol"},{"key":"2186_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1055\/s-2004-828892","volume":"24","author":"R Manfredi","year":"2004","unstructured":"Manfredi R, Barbaro B, Masselli G, Vecchioli A, Marano P: Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis. 2004, 24: 155-164.","journal-title":"Semin Liver Dis"},{"key":"2186_CR27","first-page":"548","volume":"29","author":"BI Choi","year":"2004","unstructured":"Choi BI, Lee JM, Han JK: Imaging of intrahepatic and hilar cholangiocarcinoma. Abdom Imaging. 2004, 29: 548-557.","journal-title":"Abdom Imaging"},{"key":"2186_CR28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2214\/ajr.175.3.1750721","volume":"175","author":"JW Lee","year":"2000","unstructured":"Lee JW, Han JK, Kim TK, Kim YH, Choi BI, Han MC, Suh KS, Kim SW: CT features of intraductal intrahepatic cholangiocarcinoma. Am J Roentgenol. 2000, 175: 721-725.","journal-title":"Am J Roentgenol"},{"key":"2186_CR29","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1200\/JCO.2005.11.726","volume":"23","author":"SW Oh","year":"2005","unstructured":"Oh SW, Yoon YS, Shin SA: Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea national health insurance corporation study. J Clin Oncol. 2005, 23: 4742-4754.","journal-title":"J Clin Oncol"},{"key":"2186_CR30","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3748\/wjg.v8.i5.943","volume":"8","author":"P He","year":"2002","unstructured":"He P, Shi JS, Chen WK, Wang ZR, Ren H, Li H: Multivariate statistical analysis of clinicopathologic factors influencing survival of patients with bile duct carcinoma. World J Gastroenterol. 2002, 8: 943-946.","journal-title":"World J Gastroenterol"},{"key":"2186_CR31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00535-006-1877-z","volume":"41","author":"S Miwa","year":"2006","unstructured":"Miwa S, Miyagawa S, Kobayashi A, Akahane Y, Nakata T, Mihara M, Kusama K, Soeda J, Ogawa S: Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol. 2006, 41: 893-900.","journal-title":"J Gastroenterol"},{"key":"2186_CR32","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1007\/s00268-005-7763-7","volume":"29","author":"YY Jan","year":"2005","unstructured":"Jan YY, Yeh CN, Yeh TS, Hwang TL, Chen MF: Clinicopathological factors predicting long-term overall survival after hepatectomy for peripheral cholangiocarcinoma. World J Surg. 2005, 29: 894-898.","journal-title":"World J Surg"},{"key":"2186_CR33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00534-002-0724-8","volume":"10","author":"M Ohtsuka","year":"2003","unstructured":"Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, Shimamura F, Shimizu Y, Miyazaki M: Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2003, 10: 259-264.","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"2186_CR34","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00268-001-0042-3","volume":"25","author":"T Uenishi","year":"2001","unstructured":"Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Hamba H, Tanaka H, Kinoshita H: Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma. World J Surg. 2001, 25: 865-869.","journal-title":"World J Surg"},{"key":"2186_CR35","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1067\/msy.2000.104673","volume":"127","author":"K Inoue","year":"2000","unstructured":"Inoue K, Makuuchi M, Takayama T, Torzilli G, Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Konishi M, Kinoshita T, Miyagawa S, Kawasaki S: Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery. 2000, 127: 498-505.","journal-title":"Surgery"},{"key":"2186_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s005340050093","volume":"6","author":"M Yamamoto","year":"1999","unstructured":"Yamamoto M, Takasaki K, Yoshikawa T: Extended resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg. 1999, 6: 117-121.","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"2186_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/00000658-199801000-00011","volume":"227","author":"JR Madariaga","year":"1998","unstructured":"Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish W, Starzl TE: Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg. 1998, 227: 70-79.","journal-title":"Ann Surg"},{"key":"2186_CR38","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","volume":"234","author":"WR Jarnagin","year":"2001","unstructured":"Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz J, Youssef M, Klimstra D, Blumgart LH: Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001, 234: 507-517.","journal-title":"Ann Surg"},{"key":"2186_CR39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.sla.0000149426.08580.a1","volume":"241","author":"H Lang","year":"2005","unstructured":"Lang H, Sotiropoulos GC, Fruhauf NR, Domland M, Paul A, Kind EM, Malago M, Broelsch CE: Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg. 2005, 241: 134-143.","journal-title":"Ann Surg"},{"key":"2186_CR40","first-page":"5239","volume":"11","author":"W Zgodzinski","year":"2005","unstructured":"Zgodzinski W, Espat NJ: Radiofrequency ablation for incidentally identified primary intrahepatic cholangiocarcinoma. World J Gastroenterol. 2005, 11: 5239-5240.","journal-title":"World J Gastroenterol"},{"key":"2186_CR41","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J, Investigators ABCT: Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010, 362: 1273-1281.","journal-title":"N Engl J Med"},{"key":"2186_CR42","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/01.RVI.0000143768.60751.78","volume":"16","author":"I Burger","year":"2005","unstructured":"Burger I, Hong K, Schulick R, Georgiades C, Thuluvath P, Choti M, Kamel I, Geschwind JFH: Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol. 2005, 16: 353-361.","journal-title":"J Vasc Interv Radiol"},{"key":"2186_CR43","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.crad.2010.11.002","volume":"66","author":"SY Park","year":"2011","unstructured":"Park SY, Kim JH, Yoon HJ, Lee IS, Yoon HK, Kim KP: Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma. Clin Radiol. 2011, 66: 322-328.","journal-title":"Clin Radiol"},{"key":"2186_CR44","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1007\/s00270-007-9032-7","volume":"30","author":"S Herber","year":"2007","unstructured":"Herber S, Otto G, Schneider J, Manzi N, Kummer I, Kanzier S, Schuchmann A, Thies J, Duber C, Pitton M: Transarterial Chemoembolization (TACE) for inoperable intrahepatic Cholangiocarcinoma. Cardiovasc Intervent Radiol. 2007, 30: 1156-1165.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2186_CR45","first-page":"437","volume":"24","author":"JB Kuhlmann","year":"2012","unstructured":"Kuhlmann JB, Euringer W, Spangenberg HC, Breidert M, Blum HE, Harder J, Fischer R: Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy. Eur J Gastroenterol Hepatol. 2012, 24: 437-443.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2186_CR46","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00270-008-9336-2","volume":"31","author":"C Aliberti","year":"2008","unstructured":"Aliberti C, Benea G, Tilli M, Fiorentini G: Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results. Cardiovasc Intervent Radiol. 2008, 31: 883-888.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2186_CR47","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/ijc.26407","volume":"131","author":"TJ Vogl","year":"2012","unstructured":"Vogl TJ, Naguib NN, Nour-Eldin NE, Bechstein WO, Zeuzem S, Trojan J, Gruber-Rouh T: Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: results and prognostic factors governing treatment success. Int J Cancer. 2012, 131: 733-740.","journal-title":"Int J Cancer"},{"key":"2186_CR48","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.cgh.2013.04.028","volume":"11","author":"R Salem","year":"2013","unstructured":"Salem R, Gilbertsen M, Butt Z, Memon K, Vouche M, Hickey R, Baker T, Abecassis MM, Atassi R, Riaz A, Cella D, Burns JL, Ganger D, Benson AB, Mulcahy MF, Kulik L, Lewandowski R: Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization. Clin Gastroenterol Hepatol. 2013, 11: 1358-1365.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2186_CR49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00270-011-0142-x","volume":"35","author":"RT Hoffmann","year":"2012","unstructured":"Hoffmann RT, Paprottka PM, Schon A, Bamberg F, Haug A, Durr EM, Rauch B, Trumm CT, Jakobs TF, Helmberger TK, Reiser MF, Kolligs FT: Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival. Cardiovasc Intervent Radiol. 2012, 35: 105-116.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2186_CR50","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.jvir.2009.05.030","volume":"20","author":"A Riaz","year":"2009","unstructured":"Riaz A, Lewandowski RJ, Kulik LM, Mulcahy MF, Sato KT, Ryu RK, Omary RA, Salem R: Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. J Vasc Interv Radiol. 2009, 20: 1121-1130.","journal-title":"J Vasc Interv Radiol"},{"key":"2186_CR51","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.ijrobp.2004.09.004","volume":"60","author":"AS Kennedy","year":"2004","unstructured":"Kennedy AS, Nutting C, Coldwell D, Gaiser J, Drachenberg C: Pathologic response and microdosimetry of Y-90 microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys. 2004, 60: 1552-1563.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2186_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ijrobp.2006.11.060","volume":"68","author":"A Kennedy","year":"2007","unstructured":"Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, Benson A, Espat J, Bilbao JI, Sharma RA, Thomas JP, Coldwell D: Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys. 2007, 68: 13-23.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2186_CR53","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.ijrobp.2008.10.005","volume":"74","author":"AS Kennedy","year":"2009","unstructured":"Kennedy AS, McNeillie P, Dezarn WA, Nutting C, Sangro B, Wertman D, Garafalo M, Liu D, Coldwell D, Savin M, Jakobs T, Rose S, Warner R, Carter D, Sapareto S, Nag S, Gulec S, Calkins A, Gates VL, Salem R: Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys. 2009, 74: 1494-1500.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2186_CR54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00270-006-0062-3","volume":"30","author":"L Marelli","year":"2007","unstructured":"Marelli L, Stigliano R, Triantos C, Senzolo M, Cholongitas E, Davies N, Tibballs J, Meyer T, Patch DW, Burroughs AK: Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol. 2007, 30: 6-25.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2186_CR55","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","volume":"33","author":"J Lammer","year":"2010","unstructured":"Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, Pitton M, Sergent G, Pfammatter T, Terraz S, Benhamou Y, Avajon Y, Gruenberger T, Pomoni M, Langenberger H, Schuchmann M, Dumortier J, Mueller C, Chevallier P, Lencioni R, Investigators PV: Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2010, 33: 41-52.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2186_CR56","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jvir.2011.07.002","volume":"22","author":"R Sacco","year":"2011","unstructured":"Sacco R, Bargellini I, Bertini M, Bozzi E, Romano A, Petruzzi P, Tumino E, Ginanni B, Federici G, Cioni R, Metrangolo S, Bertoni M, Bresci G, Parisi G, Altomare E, Capria A, Bartolozzi C: Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol. 2011, 22: 1545-1552.","journal-title":"J Vasc Interv Radiol"},{"key":"2186_CR57","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s00270-007-9280-6","volume":"31","author":"J Kettenbach","year":"2008","unstructured":"Kettenbach J, Stadler A, Katzler IV, Schernthaner R, Blum M, Lammer J, Rand T: Drug-loaded microspheres for the treatment of liver cancer: review of current results. Cardiovasc Intervent Radiol. 2008, 31: 468-476.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2186_CR58","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.cgh.2007.04.021","volume":"5","author":"RT Poon","year":"2007","unstructured":"Poon RT, Tso WK, Pang RW, Ng KK, Woo R, Tai KS, Fan ST: A phase I\/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol. 2007, 5: 1100-1108.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2186_CR59","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1016\/j.ejrad.2012.07.002","volume":"81","author":"M Skowasch","year":"2012","unstructured":"Skowasch M, Schneider J, Otto G, Weinmann A, Woerns MA, Dueber C, Pitton MB: Midterm follow-up after DC-BEAD-TACE of Hepatocellular Carcinoma (HCC). Eur J Radiol. 2012, 81: 3857-3861.","journal-title":"Eur J Radiol"},{"key":"2186_CR60","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM: Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010, 30: 52-60.","journal-title":"Semin Liver Dis"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-15-311.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-15-311\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-15-311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-15-311.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T23:16:06Z","timestamp":1598138166000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-15-311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,6]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2186"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-15-311","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,6]]},"assertion":[{"value":"24 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"311"}}